RLMD
Relmada Therapeutics, Inc. · Healthcare
Director Charles J Casamento sold $96K of Relmada Therapeutics, Inc.
Sold$96,342
$32.11Price
3,000Shares
−12%Stake
What RLMD did after the filing
- The stock from Tue, Jan 5 close, $32.86
- +7.0%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Feb 18 close.
Traded Mon, Jan 4. Filed Tue, Jan 5, 11:00 AM ET, during the session. Returns use the Jan 5 close and the Feb 18 close. Not investment advice.